Last update 21 Nov 2024

FB-1001

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
FB1001重组人源化单克隆抗体
+ [2]
Target
TrkB
Mechanism
TrkB stimulants(Neurotrophic tyrosine kinase receptor type 2 stimulants)
Therapeutic Areas
Eye DiseasesNervous System DiseasesCardiovascular Diseases
Active Indication
Acute angle-closure glaucomaGlaucoma, Angle-ClosureOptic Neuropathy, Ischemic+ [1]
Inactive Indication-
Originator Organization
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
Active Organization
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., LimitedFubei Biotechnology Suzhou Co. Ltd.Fubei Biotechnology Suzhou Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with FB-1001
CTR20241755 / RecruitingPhase 1
FB1001在急性视神经病变患者中单、多次给药，观察临床安全性、耐受性、药代动力学特征及探索有效性的，开放I期临床
[Translation] Phase I clinical trial of FB1001 in patients with acute optic neuropathy using single or multiple administrations to observe clinical safety, tolerability, pharmacokinetic characteristics and explore efficacy
NCT06506305 / Not yet recruitingPhase 1IIT
A Single/Multiple Dose Escalation, Open-Labeled, Phase I Clinical Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of FB1001 in Patients With Acute Optic Neuropathy
100 Clinical Results associated with FB-1001
Login to view more data
100 Translational Medicine associated with FB-1001
Login to view more data
100 Patents (Medical) associated with FB-1001
Login to view more data
100 Deals associated with FB-1001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute angle-closure glaucomaPhase 1
CN
Fubei Biotechnology Suzhou Co. Ltd.Fubei Biotechnology Suzhou Co. Ltd.
22 Aug 2024
Glaucoma, Angle-ClosurePhase 1
CN
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
15 Aug 2024
Optic Neuropathy, IschemicPhase 1
CN
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
15 Aug 2024
GlaucomaPhase 1-
4B Technologies (Beijing) Co., Limited4B Technologies (Beijing) Co., Limited
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free